Skip to content

Optical Coherence Tomography Angiography Biomarkers in Diabetic Nephropathy Patients in Thailand: A Diabetic Eye and Kidney Diseases Study

Optical Coherence Tomography Angiography Biomarkers in Diabetic Nephropathy Patients in Thailand: A Diabetic Eye and Kidney Diseases (DEK-D) Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20210308001
Enrollment
186
Registered
2021-03-08
Start date
2021-10-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic mellitus Diabetic nephropathy Diabetic retinopathy Microalbuminuria Macroalbuminuria diabetes mellitus diabetic retinopathy diabetic nephropathy microalbuminuria macroalbuminuria optical coherence tomography angiography OCTA vessel density intercapillary area

Interventions

Diabetic patients without diabetic nephropathy (define as 24-urine albumin less than 30 mg),Diabetic patients with microalbuminuria (define as 24-urine albumin between 30-300 mg),Diabetic patients wit
Diagnostic,Diagnostic,Diagnostic
No DN,Early DN,Late DN

Sponsors

Ratchadapiseksompotch Fund
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Participants aged 18-70 years with a diagnosis of type 2 diabetes mellitus according to diagnostic criteria by the American Diabetes Association 2. History of 24-urine albumin and creatinine testing within 3 months prior the recruitment 3. For no DN group, participants with 24-hour urine albumin <30 mg 4. For early DN group, participant with 24-hour urine albumin 30-300 mg 5. For late DN group, participants with 24-hour urine albumin >300 mg 6. Absence of retinal anomaly other than diabetic retinopathy

Exclusion criteria

Exclusion criteria: 1. History of ocular trauma or surgery other than uncomplicated cataract surgery 2. History corneal disorders, strabismus, nystagmus, uveitis, glaucoma, optic nerve abnormalities, neurological disorders or other abnormalities affecting the visual pathway 3. History of retinal laser treatment or intravitreal anti-vascular growth factor (anti-VEGF) treatment 4. Presence of diabetic macular edema or tractional retinal detachment 5. Media opacities preventing reliable retinal imaging 6. Active urinary tract infection 7. Suspected of any non-diabetic renal diseases 8. End-stage kidney disease requiring dialysis or kidney transplantation 9. Participants who could not cooperate adequately for the OCTA examination

Design outcomes

Primary

MeasureTime frame
Vessel density At the beginning of the study Optical coherence tomography angiography and calculated with automated software

Secondary

MeasureTime frame
Intercapillary area At the beginning of the study Optical coherence tomography angiography and calculated with automated software,FAZ area At the beginning of the study Optical coherence tomography angiography and calculated with automated software,Fractal dimension At the beginning of the study Optical coherence tomography angiography and calculated with automated software,Subfoveal choroidal thickness At the beginning of the study Optical coherence tomography angiography and calculated with automated software

Countries

Thailand

Contacts

Public ContactNuntachai Surawatsatien

Faculty of Medicine, Chulalongkorn University

nuntachais@gmail.com022564142

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026